Knee bursitis market highlights growth opportunities through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Knee Bursitis Market In 2026, And How Will Its Value Evolve By 2030?

The market for knee bursitis treatments has experienced robust expansion over recent years. This market is projected to expand from $2.86 billion in 2025 to $3.06 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. Historically, this growth has been driven by factors such as a rise in knee injuries and conditions related to repetitive stress, increased involvement in sports and physical activities, the well-established application of imaging techniques in musculoskeletal diagnosis, an expanding elderly demographic experiencing joint disorders, and the accessibility of anti-inflammatory medications.

The knee bursitis market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $3.92 billion by 2030, showing a compound annual growth rate (CAGR) of 6.4%. This projected growth during the forecast period is due to factors like an increasing demand for minimally invasive treatments, a heightened focus on early diagnosis and prevention, the growing acceptance of physiotherapy services, the expansion of orthopedic care infrastructure, and improved access to diagnostic imaging in emerging markets. Significant trends for this period include a rising preference for non-surgical knee bursitis management, more frequent use of imaging for accurate diagnosis, a surge in the adoption of physical therapy and rehabilitation, the broadening of outpatient and conservative treatment approaches, and enhanced patient awareness regarding early knee injury care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Key Drivers Are Affecting The Knee Bursitis Market Development?

The expanding incidence of bone-related ailments is projected to boost the expansion of the Knee Bursitis Market in the future. These conditions, including osteoporosis, arthritis, and bone cancer, compromise the skeletal system’s structure, strength, and functionality. The rising occurrence of such diseases is linked to factors like an aging demographic, inactive routines, inadequate nutrition, and shifts in environmental conditions. Specifically, bone conditions such as osteoarthritis and rheumatoid arthritis can trigger knee bursitis by inducing inflammation and undue stress on the knee bursa, leading to discomfort, swelling, and diminished joint movement. An example of this trend is seen in Australia; as per Healthy Bones Australia, a national nonprofit organization dedicated to osteoporosis prevention and bone health awareness, an estimated 6.2 million Australians aged 50 and over, representing about 67% of this demographic, experienced poor bone health in October 2024. This figure is expected to climb considerably, potentially reaching approximately 7.7 million people with osteopenia or osteoporosis by 2033. Consequently, the growing prevalence of bone-related diseases is propelling the growth of the Knee Bursitis Market.

How Are Different Segments Classified In The Knee Bursitis Market Segment Analysis?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Who Are The Companies Driving Activity In The Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Get The Full Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Region Has The Greatest Market Share In The Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Knee Bursitis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Browse Through More Reports Similar to the Global Knee Bursitis Market 2026, By The Business Research Company

Gouty Arthritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoarthritis Market Report

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Knee Implants Market Report

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795